E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/15/2006 in the Prospect News Biotech Daily.

Kyphon expands, opens business unit in Switzerland

By Elaine Rigoli

Tampa, Fla., March 15 - Kyphon, Inc. announced that it is establishing an operational presence in the Canton of Neuchatel, Switzerland, to support the company's rapid international growth.

Kyphon Sarl, the newly created Swiss company, will house manufacturing and distribution activities for Kyphon's international markets, as well as administrative activities including clinical, regulatory, marketing and shared financial services, according to a company news release.

In addition, certain global research and development activities will be performed by Kyphon Sarl, which will serve to augment Kyphon's current research and development center in Sunnyvale, Calif.

Kyphon's international revenues increased 87% in 2005 versus the prior year, with international markets representing 19% of the company's global sales during the most recent reporting quarter, the release said.

The decision to establish a major facility overseas was in response to the growing needs of Kyphon's international markets, coupled with the company's desire to establish additional manufacturing capacity and gain access to new technical talent.

Kyphon Sarl is beginning administrative operations immediately, and anticipates that it will have full manufacturing, distribution, research and development and administrative activities in effect by the end of 2007, the release said.

Kyphon develops and markets medical devices designed to restore spinal function using minimally invasive technologies.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.